AAN 2022

April 02-07, 2022
Seattle, WA

74th Annual Meeting of the American Academy of Neurology
Explore more Epilepsy congress materials
Material Type

Results(12)

Neuroscience
Effect of Add-on Cannabidiol (CBD) on Seizure Frequency and Seizure-Free Intervals in Patients With Seizures Associated With Tuberous Sclerosis Complex (TSC): Phase 3 Trial GWPCARE6 Post Hoc Analysis
Author(s): Elizabeth Thiele MD, PhD, Massachusetts General Hospital, et al.
Seizure-Related Outcomes With Real-World Use of Cannabidiol (CBD) in Lennox-Gastaut Syndrome and Dravet Syndrome: BECOME, A Caregiver Survey
Author(s): Tracy Dixon-Salazar Ph.D., LGS Foundation, et al.
Non-Seizure-Related Outcomes With Real-World Use of Cannabidiol (CBD) in Lennox-GastautSyndrome and Dravet Syndrome: BECOME, A Caregiver Survey
Author(s): Ann T. Berg PhD, Northwestern University Feinberg School of Medicine, et al.